產(chǎn)品詳情
簡單介紹:
AG-221(Enasidenib)
詳情介紹:
Purpose | A potent IDH2 (Isocitrate dehydrogenase 2) inhibitor |
Characteristics | AG-221(Enasidenib) is a potent, selective, and reversible inhibitor of mutant IDH2 (isocitrate dehydrogenase type 2). It specifically inhibits IDH2 in the mitochondria, blocking the formation of oncometabolite 2-hydroxyglutarate (2HG). In in vitro studies, AG-221 reduces 2-HG levels by >90%, reverses histone and DNA hypermethylation, and induces cellular differentiation in leukemia cell models. |
Purity | ≥ 98?% by HPLC |
Chemical Name | 2-methyl-1-((4-(6-(trifluoromethyl)pyridin-2-yl)-6-((2-(trifluoromethyl)pyridin-4-yl)amino)-1,3,5-triazin-2-yl)amino)propan-2-ol |
Formula | C??H??F?N?O |
Permeability | Cell-permeable |
Solubility | DMSO (>30 mg/ml) |
Molecular Weight | 473.38 g/mol |
CAS-No | 1446502-11-9 |
Restrictions | For Research Use only |
Format | Solid |
Handling Advice | Protect from air and light |
Storage | -20 °C |
Expiry Date | 36 months |